Literature DB >> 18846348

Detection of V, III and I type collagens of dermal tissues in skin lesions of patients with systemic sclerosis and its implication.

Tong Liu1, Jian Zhang.   

Abstract

This study investigated the contents and distribution of collagen V (Col V) in skin lesions of the patients with systemic sclerosis (SSc) and its roles in the pathogenesis. The contents and distribution for alpha1 chain of collagen type I, III and V [alpha1 (I), alpha1 (III) and alpha1 (V)] in skin lesions of 36 patients with SSc (9 cases of mild fibrosis, 14 moderate, and 13 severe) were detected by using immunohistochemical SP method. Six cases of normal skin tissues served as controls. The results showed that there was diffuse distribution for three kinds of collagens in dermis. The deep staining alpha1 (I) and alpha1 (III) masses or bands were seen in reticular layer, while alpha1 (V) was distributed more homogeneously. From control to weak, moderate and severe fibrosis stages, alpha1 (I), alpha1 (III) and alpha1 (V) showed a gradually increased trend in skin lesions (P<0.05). alpha1 (V) was obviously elevated in skin lesions at early stage and persisted in whole fibrotic process and risen in greater contents, while alpha1 (I) and alpha1 (III) were to go higher late and were apparently elevated at moderate and late stages. Compared with alpha1 (I), alpha1 (V) took leading increase at early stage in skin lesions (P<0.01), and had more elevated contents than alpha1 (III) at moderate and late stages. The fibrotic changes in dermal reticular layer occurred earlier than those in papillary layer, and the abnormalities of alpha1 (V)/alpha1 (I) ratio appeared before alpha1 (III)/alpha1 (I) ratio. It was concluded that a lot of alpha1 (V) began to deposit in greater contents prior to alpha1 (I) and alpha1 (III) at early stage in SSc and persisted in whole fibrotic process. The changes of alpha1 (V) contents in reticular layer occurred earlier than those in papillary layer, and it suggested that the fibrosis in reticular layer appeared earlier.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18846348     DOI: 10.1007/s11596-008-0525-7

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  17 in total

1.  Development of a functional skin matrix requires deposition of collagen V heterotrimers.

Authors:  Hélène Chanut-Delalande; Christelle Bonod-Bidaud; Sylvain Cogne; Marilyne Malbouyres; Francesco Ramirez; Agnès Fichard; Florence Ruggiero
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

2.  A comprehensive study of the spatial and temporal expression of the col5a1 gene in mouse embryos: a clue for understanding collagen V function in developing connective tissues.

Authors:  Muriel Roulet; Florence Ruggiero; Gérard Karsenty; Dominique LeGuellec
Journal:  Cell Tissue Res       Date:  2006-10-06       Impact factor: 5.249

3.  Anti-type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well-healed lung transplants.

Authors:  S Yoshida; A Haque; T Mizobuchi; T Iwata; M Chiyo; T J Webb; L A Baldridge; K M Heidler; O W Cummings; T Fujisawa; J S Blum; D D Brand; D S Wilkes
Journal:  Am J Transplant       Date:  2006-04       Impact factor: 8.086

4.  Scleroderma-like remodeling induced by type V collagen.

Authors:  Mailze Campos Bezerra; Walcy Rosolia Teodoro; Cristiane Carla de Oliveira; Ana Paula Pereira Velosa; Luciana Tsuzuki Ichicawa Ogido; Giancarla Gauditano; Edwin Roger Parra; Vera Luiza Capelozzi; Natalino Hajime Yoshinari
Journal:  Arch Dermatol Res       Date:  2006-05-03       Impact factor: 3.017

Review 5.  Systemic sclerosis: a prototypic multisystem fibrotic disorder.

Authors:  John Varga; David Abraham
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

6.  Collagen V nasal tolerance in experimental model of systemic sclerosis.

Authors:  Ana Paula Pereira Velosa; Walcy Rosolia Teodoro; Cristiane Carla de Oliveira; Antonio Dos Santos Filho; Rodnei Francisco Moutinho; Angela Gomes Santos; Margarete Borges Galhardo Vendramini; Cleonice Bueno; Edwin Roger Parra; Vera Luiza Capelozzi; Natalino Hajime Yoshinari
Journal:  Arch Dermatol Res       Date:  2007-02-13       Impact factor: 3.017

7.  Type V collagen controls the initiation of collagen fibril assembly.

Authors:  Richard J Wenstrup; Jane B Florer; Eric W Brunskill; Sheila M Bell; Inna Chervoneva; David E Birk
Journal:  J Biol Chem       Date:  2004-09-21       Impact factor: 5.157

8.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

9.  Type V collagen regulates the expression of apoptotic and stress response genes by breast cancer cells.

Authors:  Claudio Luparello; Rosalia Sirchia
Journal:  J Cell Physiol       Date:  2005-02       Impact factor: 6.384

10.  Murine model of the Ehlers-Danlos syndrome. col5a1 haploinsufficiency disrupts collagen fibril assembly at multiple stages.

Authors:  Richard J Wenstrup; Jane B Florer; Jeffrey M Davidson; Charlotte L Phillips; Brent J Pfeiffer; Diana W Menezes; Inna Chervoneva; David E Birk
Journal:  J Biol Chem       Date:  2006-02-20       Impact factor: 5.157

View more
  3 in total

1.  Degradation of human collagen isoforms by Clostridium collagenase and the effects of degradation products on cell migration.

Authors:  Lei Shi; Ryan Ermis; Anastacia Garcia; Dale Telgenhoff; Duncan Aust
Journal:  Int Wound J       Date:  2010-04       Impact factor: 3.315

2.  Intrinsic gene expression subsets of diffuse cutaneous systemic sclerosis are stable in serial skin biopsies.

Authors:  Sarah A Pendergrass; Raphael Lemaire; Ian P Francis; J Matthew Mahoney; Robert Lafyatis; Michael L Whitfield
Journal:  J Invest Dermatol       Date:  2012-02-09       Impact factor: 8.551

3.  Identification of Autoimmunity to Peptides of Collagen V α1 Chain as Newly Biomarkers of Early Stage of Systemic Sclerosis.

Authors:  Ana Paula Pereira Velosa; Lais Brito; Zelita Aparecida de Jesus Queiroz; Solange Carrasco; Jurandir Tomaz de Miranda; Cecília Farhat; Cláudia Goldenstein-Schainberg; Edwin Roger Parra; Danieli Castro Oliveira de Andrade; Pedro Leme Silva; Vera Luiza Capelozzi; Walcy Rosolia Teodoro
Journal:  Front Immunol       Date:  2021-02-12       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.